A group of pediatricians in England commissioned the British Paediatri
c Association Surveillance Unit (BPASU) to include Kawasaki disease in
their reporting scheme. Every practicing pediatrician is circulated a
survey form monthly by the BPASU and is asked to indicate whether the
y have treated a child with a number of uncommon conditions. Kawasaki
disease was included during 1990, and the results will be presented. 1
63 patients were identified, of whom 6 (3.7%) died. 45 children 28% de
veloped cardiac complications of which 39 (24%) were abnormalities of
the coronary arteries. In 5 children the diagnosis was not made until
post mortem. Coronary artery abnormalities were associated with a high
platelet count, high white count, long period of fever, and younger a
ge 139 children (87%) received aspirin and only 93 (61%) where given i
ntravenous gammaglobulin. The incidence of coronary abnormalities was
similar in those heated with IVGG (29%) and those untreated (20%) incl
uding those treated within 10 days of onset. We were surprised by thes
e results but they may be because (1) children who received IVGG had m
ore serious disease (2) Kawasaki disease in the UK is different from t
hat seen elsewhere, and the IVGG preparation is less effective.